Thu, Jun 08
|Virtual Event via Zoom
FDA Oncology Center of Excellence Presents
FDA Listening Session "Drug Development in Molecular Subsets of Non-Small Cell Lung Cancer – Challenges and Opportunities from a Patient Perspective”
Time & Location
Jun 08, 2:30 PM – 4:00 PM
Virtual Event via Zoom
About the Event
Register now to join FDA and the representatives from the following patient advocacy groups:
ALK Fusion; ALK Positive, BRAF Bombers, EGFR Resisters, Exon 20 Group at ICAN, KRAS Kickers, MET Crusaders, NTRKers, RET Renegades and the ROS1ders
Discussion topics includes:
- Targeted Therapy Clinical Trials
- Survivorship and Quality of Life
- Biomarker Testing
Date: June 8, 2023, 2:30-4:00 pm, ET
Coordinators: Drs. Luckson Mathieu, Satinder (Mona) Choudhary, and Harpreet Singh
After registering, you will receive a confirmation email containing the link and information to join the webinar on June 8th.
Register:
https://fda.zoomgov.com/webinar/register/WN_I7xkiO9cRKKl1MA7AwHjUA